AstraZeneca - Biologics Day Interviews With Sen...

LONDON, December 7 /PRNewswire/ --     David Brennan, AstraZeneca CEO, and 
senior management from AstraZeneca 
(LSE: AZN) (NYSE: AZN) and MedImmune discuss opportunities in the biologics 
field, R&D and portfolio progress plus the Group's current focus and 
priorities. Video interviews and transcripts are available now on 
http://www.cantos.com.



    It's free to view. All you need to do is register at 
http://www.cantos.com.



    Cantos.com is an online financial website featuring in-depth interviews,
documentaries and webcasts with senior company executives addressing the 
critical issues facing their businesses. If you would like
to contact us, please email [e-mail] or phone [phone].